DK1214440T3 - Sekvensspecifik DNA-rekombination i eukaryote celler - Google Patents

Sekvensspecifik DNA-rekombination i eukaryote celler

Info

Publication number
DK1214440T3
DK1214440T3 DK00965792T DK00965792T DK1214440T3 DK 1214440 T3 DK1214440 T3 DK 1214440T3 DK 00965792 T DK00965792 T DK 00965792T DK 00965792 T DK00965792 T DK 00965792T DK 1214440 T3 DK1214440 T3 DK 1214440T3
Authority
DK
Denmark
Prior art keywords
sequence
derivatives
eukaryotic cells
specific dna
dna recombination
Prior art date
Application number
DK00965792T
Other languages
Danish (da)
English (en)
Inventor
Peter Droege
Nicole Christ
Elke Lorbach
Original Assignee
Peter Droege
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peter Droege filed Critical Peter Droege
Application granted granted Critical
Publication of DK1214440T3 publication Critical patent/DK1214440T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK00965792T 1999-08-30 2000-08-29 Sekvensspecifik DNA-rekombination i eukaryote celler DK1214440T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19941186A DE19941186A1 (de) 1999-08-30 1999-08-30 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen

Publications (1)

Publication Number Publication Date
DK1214440T3 true DK1214440T3 (da) 2006-10-30

Family

ID=7920135

Family Applications (2)

Application Number Title Priority Date Filing Date
DK00965792T DK1214440T3 (da) 1999-08-30 2000-08-29 Sekvensspecifik DNA-rekombination i eukaryote celler
DK06008807T DK1681355T3 (da) 1999-08-30 2000-08-29 Sekvensspecifik DNA-rekombination i eukaryote celler

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK06008807T DK1681355T3 (da) 1999-08-30 2000-08-29 Sekvensspecifik DNA-rekombination i eukaryote celler

Country Status (19)

Country Link
US (2) US20030027337A1 (es)
EP (2) EP1681355B1 (es)
JP (1) JP2003520028A (es)
KR (1) KR100490188B1 (es)
CN (1) CN1182247C (es)
AT (2) ATE446373T1 (es)
AU (1) AU776297B2 (es)
CA (1) CA2390526C (es)
CY (2) CY1105288T1 (es)
CZ (1) CZ302620B6 (es)
DE (3) DE19941186A1 (es)
DK (2) DK1214440T3 (es)
ES (2) ES2334577T3 (es)
HK (1) HK1047129B (es)
IL (2) IL148152A0 (es)
MX (1) MX244498B (es)
PT (2) PT1681355E (es)
SK (1) SK286034B6 (es)
WO (1) WO2001016345A2 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964861B1 (en) 1998-11-13 2005-11-15 Invitrogen Corporation Enhanced in vitro recombinational cloning of using ribosomal proteins
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US7351578B2 (en) * 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US20030124555A1 (en) * 2001-05-21 2003-07-03 Invitrogen Corporation Compositions and methods for use in isolation of nucleic acid molecules
IL135776A0 (en) * 1997-10-24 2001-05-20 Life Technologies Inc Recombinational cloning using nucleic acids having recombination sites
DE60042969D1 (de) 1999-03-02 2009-10-29 Life Technologies Corp Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
US7244560B2 (en) 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7198924B2 (en) * 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
CA2444195A1 (en) * 2001-04-19 2002-10-31 Invitrogen Corporation Compositions and methods for recombinational cloning of nucleic acid molecules
NZ545697A (en) * 2001-05-30 2008-06-30 Glaxo Group Ltd A lambda-intR mutein comprising a glutamic acid to arginine change at position 174 of Wt lambda-intR
EP2390256A1 (en) * 2001-05-30 2011-11-30 Agrisoma, Inc. Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
CA2480642C (en) 2002-03-29 2012-10-16 Janet Louise Suttie Lambda integrase mediated recombination in plants
AU2003253992A1 (en) * 2002-07-18 2004-02-09 Robert P. Bennett Viral vectors containing recombination sites
US7491539B2 (en) 2002-12-05 2009-02-17 Boehringer Ingelheim Pharma Kg Sequence specific DNA recombination in eukaryotic cells
TW200502390A (en) * 2002-11-28 2005-01-16 Peter Droege Sequence specific DNA recombination in eukaryotic cells
US20050095615A1 (en) * 2003-06-26 2005-05-05 Welch Peter J. Methods and compositions for detecting promoter activity and expressing fusion proteins
EP2484687A3 (en) 2003-08-08 2012-11-14 Life Technologies Corporation Methods and compositions for seamless cloning of nucleic acid molecules
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US7935862B2 (en) 2003-12-02 2011-05-03 Syngenta Participations Ag Targeted integration and stacking of DNA through homologous recombination
CA2653992C (en) 2006-06-03 2017-05-23 Syngenta Participations Ag Corn event mir162
WO2009068645A1 (en) * 2007-11-30 2009-06-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel recombination sequences
CN102604936B (zh) * 2011-01-21 2013-09-04 上海市儿童医院 羊基因组中被噬菌体*c31整合酶识别的dna及其应用
EP2739738B1 (en) 2011-08-03 2018-06-20 Ramot at Tel Aviv University, Ltd. Use of integrase for targeted gene expression
CN102533741B (zh) * 2011-12-09 2014-09-24 深圳华大基因研究院 猪假attp位点及其用途
US11078493B2 (en) 2016-06-21 2021-08-03 Nanyang Technological University Site-specific DNA recombination
US11845954B2 (en) 2017-06-14 2023-12-19 Technische Universität Dresden Methods and means for genetic alteration of genomes utilizing designer DNA recombining enzymes
WO2023237453A1 (en) * 2022-06-07 2023-12-14 Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement Attp mv4-derived site-specific recombination and its use for integration of sequence of interest

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US7118911B1 (en) * 1990-03-05 2006-10-10 Genzyme Corporation DNA molecules stabilized for propagation in bacterial cells that encode cystic fibrosis transmembrane conductance regulator
US5227288A (en) * 1990-10-01 1993-07-13 Blattner Frederick R DNA sequencing vector with reversible insert
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5861273A (en) * 1993-12-21 1999-01-19 Celtrix Phamraceuticals, Inc. Chromosomal expression of heterologous genes in bacterial cells
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
WO1996040724A1 (en) * 1995-06-07 1996-12-19 Life Technologies, Inc. Recombinational cloning using engineered recombination sites
DE19530412A1 (de) * 1995-08-18 1997-02-20 Harald Von Prof Dr Melchner Selbst deletierende retrovirale Vektoren für die Gentherapie
FR2741892B1 (fr) * 1995-12-04 1998-02-13 Pasteur Merieux Serums Vacc Procede de preparation d'une banque multicombinatoire de vecteurs d'expression de genes d'anticorps, banque et systemes d'expression d'anticorps "coliclonaux" obtenus
US5928914A (en) * 1996-06-14 1999-07-27 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Methods and compositions for transforming cells
WO1998027207A1 (en) * 1996-12-18 1998-06-25 Targeted Genetics Corporation Recombinase-activatable aav packaging cassettes for use in the production of aav vectors
US5851808A (en) * 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
IL135776A0 (en) * 1997-10-24 2001-05-20 Life Technologies Inc Recombinational cloning using nucleic acids having recombination sites
US6632672B2 (en) * 1998-08-19 2003-10-14 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification

Also Published As

Publication number Publication date
CY1105288T1 (el) 2010-03-03
EP1214440A2 (de) 2002-06-19
HK1047129B (zh) 2006-10-20
DE50015772D1 (de) 2009-12-03
CN1182247C (zh) 2004-12-29
MXPA02002036A (es) 2003-08-20
CZ302620B6 (cs) 2011-08-03
US20130133092A1 (en) 2013-05-23
AU7642900A (en) 2001-03-26
JP2003520028A (ja) 2003-07-02
KR20020057953A (ko) 2002-07-12
DE19941186A1 (de) 2001-03-01
ATE446373T1 (de) 2009-11-15
KR100490188B1 (ko) 2005-05-17
DE50013093D1 (de) 2006-08-10
IL148152A (en) 2007-10-31
HK1047129A1 (en) 2003-02-07
SK286034B6 (sk) 2008-01-07
CN1387576A (zh) 2002-12-25
DK1681355T3 (da) 2009-12-14
PT1214440E (pt) 2006-11-30
CA2390526C (en) 2010-10-19
WO2001016345A2 (de) 2001-03-08
ES2334577T3 (es) 2010-03-12
EP1214440B1 (de) 2006-06-28
CA2390526A1 (en) 2001-03-08
SK3042002A3 (en) 2002-07-02
EP1681355A1 (de) 2006-07-19
EP1681355B1 (de) 2009-10-21
MX244498B (es) 2007-03-28
ES2267567T3 (es) 2007-03-16
CZ2002756A3 (cs) 2002-06-12
US20030027337A1 (en) 2003-02-06
ATE331802T1 (de) 2006-07-15
IL148152A0 (en) 2002-09-12
PT1681355E (pt) 2010-01-27
AU776297B2 (en) 2004-09-02
CY1110590T1 (el) 2015-04-29
WO2001016345A3 (de) 2001-12-06

Similar Documents

Publication Publication Date Title
DK1214440T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
SG147468A1 (en) High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
FI970983A (fi) Molekyylien siirto solujen sytoplasmaan
BR0010725A (pt) Expressão e exportação de proteìnas de interferon-alfa como proteìnas de fusão de fc
BR9913331A (pt) Expressão e exportação de inibidores de angiogênese como imunofusinas
DE69822206D1 (de) Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
DK639689D0 (da) Indfoering af dna i celler
ATE338821T1 (de) Strukturprotein von aav, seine herstellung und verwendung
IL180924A (en) Method for regulating cell proliferation and cell death
ZA971158B (en) Nucleic acid constructs for the cell cycle-regulated expression of genes, cells containing such constructs and their use for preparing drugs.
BR9806866A (pt) Cassete de expressão e uso do mesmo, cepa do cassete de expressão, vetor de ácido nucleico, cepa viral, composição farmacêutica, e, processos para estudar a função de um ou mais genes heterólogos em uma célula eucariótica, para produzir uma cepa de hsv, para tratamento do corpo humano ou animal e para realizar terapia genética em um humano ou animal, e, vacina.
RU95115686A (ru) Премерсацидин, промерсацидин, днк, вектор, клетка-хозяин, способ получения
BR9811014A (pt) "região concentrada reguladora de gene especìfica para semente precoce"
AU5318496A (en) Adenovirus vectors for gene therapy
DK1131408T3 (da) Celler, dyrkningsmetoder og deres anvendelse ved autolog transplantationsbehandling
WO2004013313A3 (en) Antisense nucleic acids
HUP0202722A2 (hu) Szekvencia-specifikus DNS-rekombináció eukarióta sejtekben
EP0154566A3 (en) Viral enhancer dna segments
HUP0102413A1 (hu) Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk
IL131436A0 (en) Compositions for treatment of disorders involving programmed cell death
ATE292174T1 (de) Gentransfer in humane lymphocyten mittels retroviraler scfv-zelltargeting vektoren
EP1094115A4 (en) NEGATIVE STRENGTH RNA VIRUS VECTOR
SETLOW Studies on bacterial spore ultraviolet light resistance and regulation of the activity of a spore protease(Final Report, 1 May 1990- 31 Oct. 1993)
BR9810643A (pt) Genes e proteìnas de telomerase de vertebrado, eutilização dos mesmos
NZ501962A (en) Vertebrate telomerase genes and proteins and uses thereof